Editor’s Note October 17, 2011

As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:

Gonzague Issenman, CEO of STENTYS [EPA:STNT] admits the company may solve one of the biggest problems in treating Acute Coronary Syndrome.

Zosano Pharma, Inc. and Asahei Kasei Pharma formed a collaboration to develop Teribone, a patch treatment for osteoporosis. This transdermal technology provides efficient delivery using a noninvasive and painless system.

Peter Winter, consultant to the biotechnology industry, brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

The comments are closed.